Evidence map›Paper›PMID 41484571›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Correction: SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2025).

Maria José Safont Aguilera, Ferran Losa Gaspá, Encarna González-Flores, María Luisa Limón Mirón, José Luis Manzano Mozo, María Del Carmen Riesco Martínez, Rosario Vidal-Tocino, Vicente Alonso Orduña, Elena Asensio Martínez, Ruth Vera García

Abstract readPublished Erratum
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Maria José Safont AguileraDepartment of Oncology, Consorcio Hospital General Universitario de Valencia, Universitat de Valencia, CIBERONC, Valencia, Spain.
Ferran Losa GaspáDepartment of Oncology, Hospital Sant Joan Despí-Moisés Broggi/ICO-Hospitalet, Barcelona, Spain. flosa@csi.cat.ORCID http://orcid.org/0000-0003-0111-8708
Encarna González-FloresDepartment of Oncology, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria IBS, Granada, Spain.
María Luisa Limón MirónDepartment of Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain.
José Luis Manzano MozoDepartment of Oncology, Institut Català d'Oncologia (ICO)-Badalona, Barcelona, Spain.
María Del Carmen Riesco MartínezDepartment of Oncology, Hospital Universitario, 12 de Octubre, Madrid, Spain.
Rosario Vidal-TocinoDepartment of Oncology, Instituto de Investigación Biomédica de Salamanca (IBSAL), Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
Vicente Alonso OrduñaDepartment of Oncology, Hospital Universitario Miguel Servet, Saragossa, Spain.
Elena Asensio MartínezDepartment of Oncology, Hospital General Universitario de Elche, Alicante, Spain.
Ruth Vera GarcíaDepartment of Oncology, Instituto de Investigación Sanitaria de Navarra, IdISNA, University Hospital of Navarra, Pamplona, Navarra, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41484571
PMCPMC12855309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.